Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Humalog (insulin lispro) and Apidra (insulin glulisine) are both rapid-acting insulins used to control blood sugar in people with diabetes. Humalog can be used in children as young as 3 years old with Type 1 diabetes, while Apidra is approved for children 4 years and older. Humalog is typically injected within 15 minutes before or right after a meal, whereas Apidra can be injected within 15 minutes before or up to 20 minutes after starting a meal. Both medications are available in vials and prefilled pens, but Apidra can also be given through an IV injection in a hospital setting. Humalog and Apidra can be mixed with NPH insulin within the same syringes, but not with other insulins. Both medications have similar side effects, such as low blood sugar and weight gain, but Apidra has a slightly higher risk of causing low blood sugar in children.
Humalog (insulin lispro)
Apidra (insulin glulisine)
Humalog (insulin lispro)
Apidra (insulin glulisine)
Summary of Humalog vs. Apidra
Summary for Insulin
Prescription only
Humalog (insulin lispro) is a fast-acting insulin for adults and children with diabetes. It helps prevent and treat high blood sugar from meals. This medication lowers your blood sugar levels by moving the sugar from your blood and into your body. Humalog (insulin lispro) is typically given as an injection under the skin. In certain situations, it's injected into the veins by a healthcare provider. Humalog (insulin lispro) is available as vials and ready-to-use prefilled pens. Side effects include headache and low blood sugar (hypoglycemia).
Summary for Insulin
Prescription only
Insulin glulisine is a rapid-acting insulin that's available as a vial (Apidra) and a pre-filled pen (Apidra Solostar). It's used to control blood sugar from meals for people with either Type 1 diabetes (T1D) or Type 2 diabetes (T2D). Apidra (insulin glulisine) is given under the skin as either a quick injection or continuously through an insulin pump. It can also be given as an injection through the veins (IV) for people in the hospital. Side effects include low blood sugar (hypoglycemia) and common cold symptoms.